Directory
>
Johanna Shulman
Johanna Shulman
Senior Product Manager | Karyopharm Therapeutics Inc.
Los Angeles Metropolitan Area United States, United States
Johanna Shulman
Summary
Johanna Shulman is a seasoned executive in the biotechnology sector, currently serving as Vice President and Program Lead for Myelofibrosis at Karyopharm Therapeutics Inc. With a robust background in oncology and hematology, she has held pivotal roles at major pharmaceutical companies like Amgen and Novartis. Johanna's expertise in commercialization strategy and product development has significantly impacted the launch of innovative therapies in rare diseases. She holds a Master's degree in Molecular Genetics from the University of Toronto and a Bachelor's degree in Biology from Queen's University. Johanna is known for her strategic leadership and ability to navigate complex market dynamics, making her a valuable asset in the life sciences industry. Her passion for advancing patient care drives her commitment to innovation and excellence in her field.
Johanna Shulman
Work Experience
Vice President, Program Lead-Myelofibrosis at
Karyopharm Therapeutics Inc.
August 2022 - Present
Johanna Shulman
Education
Queen's University, B.Sc (Hons), Biology
University of Toronto, M.Sc, Molecular Genetics
Frequently Asked Questions about Johanna Shulman
What is Johanna Shulman email address?
Johanna Shulman's primary email address is ********@amgen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Johanna Shulman work for?
Johanna Shulman is a Senior Product Manager at Karyopharm Therapeutics Inc..
Where Johanna Shulman graduated from?
Johanna Shulman holds a degree in null from Queen's University.
How can I directly contact Johanna Shulman?
To contact Johanna Shulman directly, you can use the email address ********@amgen.com. Complete contact information is available upon registration with Muraena.
Is Johanna Shulman an immigrant?
Yes, Johanna Shulman is an immigrant and currently based in United States
Who is Johanna Shulman?
Johanna Shulman is a seasoned executive in the biotechnology sector, currently serving as Vice President and Program Lead for Myelofibrosis at Karyopharm Therapeutics Inc. With a robust background in oncology and hematology, she has held pivotal roles at major pharmaceutical companies like Amgen and Novartis. Johanna's expertise in commercialization strategy and product development has significantly impacted the launch of innovative therapies in rare diseases. She holds a Master's degree in Molecular Genetics from the University of Toronto and a Bachelor's degree in Biology from Queen's University. Johanna is known for her strategic leadership and ability to navigate complex market dynamics, making her a valuable asset in the life sciences industry. Her passion for advancing patient care drives her commitment to innovation and excellence in her field.
Johanna`s contact details
********@amgen.com
Colleagues
Project Coordinator
Research Scientist
Business Developer
President and CEO
Sales Representative
Research Associate
Co-Op
Scientist
Quality Control Technician/Customer Service Manager
Sr. Manager, Publications